X-rays predict likelihood of death from SARS

Article

A retrospective review of patients with severe acute respiratory syndrome revealed that chest x-rays taken seven days after onset of symptoms could predict the likelihood of death.

A retrospective review of patients with severe acute respiratory syndrome revealed that chest x-rays taken seven days after onset of symptoms could predict the likelihood of death.

Dr. Gregory Antonio and colleagues at the Chinese University of Hong Kong examined radiographic records for 313 SARS patients. They analyzed the percentage area of lung opacification and the number of lung zones affected, allocating radiographic scores accordingly. Univariate logistical regression models for these scores for each of the first 12 days after symptom onset showed day seven to be the earliest point at which reliable prognosis could be made.

"If patients could be stratified according to risk early in their illness, different arms of a treatment protocol could be devised, and individual treatment could be tailored," the researchers wrote in the March issue of the American Journal of Roentgenology.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.